Search
Descriptor English: Antineoplastic Combined Chemotherapy Protocols
Descriptor Spanish: Protocolos de Quimioterapia Combinada Antineoplásica
Descriptor protocolos de quimioterapia antineoplásica combinada
Entry term(s) antineoplásicos combinados
combinaciones de antineoplásicos
combinaciones de medicamentos frente al cáncer
combinación de antineoplásicos
protocolos antineoplásicos de quimioterapia
protocolos de quimioterapia antineoplásica
protocolos de quimioterapia frente al cáncer
Scope note: Empleo simultáneo o secuencial de dos o más productos en el tratamiento medicamentoso de las neoplasias. No es necesario que los quimioterápicos tengan la misma forma farmacéutica.
Descriptor Portuguese: Protocolos de Quimioterapia Combinada Antineoplásica
Descriptor French: Protocoles de polychimiothérapie antinéoplasique
Entry term(s): Agent, Combined Antineoplastic
Agents, Combined Antineoplastic
Anticancer Drug Combination
Anticancer Drug Combinations
Antineoplastic Agent, Combined
Antineoplastic Agents, Combined
Antineoplastic Chemotherapy Protocol
Antineoplastic Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Regimens
Antineoplastic Drug Combination
Antineoplastic Drug Combinations
Cancer Chemotherapy Protocol
Cancer Chemotherapy Protocols
Chemotherapy Protocol, Antineoplastic
Chemotherapy Protocol, Cancer
Chemotherapy Protocols, Antineoplastic
Chemotherapy Protocols, Cancer
Combinations, Antineoplastic Drug
Combined Antineoplastic Agent
Combined Antineoplastic Agents
Drug Combination, Anticancer
Drug Combination, Antineoplastic
Drug Combinations, Anticancer
Drug Combinations, Antineoplastic
Protocol, Antineoplastic Chemotherapy
Protocol, Cancer Chemotherapy
Protocols, Antineoplastic Chemotherapy
Protocols, Cancer Chemotherapy
Tree number(s): E02.183.750.500
E02.319.077.500
E02.319.310.037
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000971
Scope note: The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Annotation: coordinate IM with specific antineoplastic agents (IM or NIM)
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Drug Therapy, Combination (1974-1983)
Public MeSH Note: 2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001)
History Note: 2002(1984)
DeCS ID: 23947
Unique ID: D000971
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1984/01/01
Date of Entry: 1983/06/17
Revision Date: 2015/06/23
Antineoplastic Combined Chemotherapy Protocols - Preferred
Concept UI M0001485
Scope note The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Preferred term Antineoplastic Combined Chemotherapy Protocols
Entry term(s) Agent, Combined Antineoplastic
Agents, Combined Antineoplastic
Anticancer Drug Combination
Anticancer Drug Combinations
Antineoplastic Agent, Combined
Antineoplastic Agents, Combined
Antineoplastic Combined Chemotherapy Regimens
Antineoplastic Drug Combination
Antineoplastic Drug Combinations
Combinations, Antineoplastic Drug
Combined Antineoplastic Agent
Combined Antineoplastic Agents
Drug Combination, Anticancer
Drug Combination, Antineoplastic
Drug Combinations, Anticancer
Drug Combinations, Antineoplastic
Antineoplastic Chemotherapy Protocols - Broader
Concept UI M0369990
Preferred term Antineoplastic Chemotherapy Protocols
Entry term(s) Antineoplastic Chemotherapy Protocol
Cancer Chemotherapy Protocol
Cancer Chemotherapy Protocols
Chemotherapy Protocol, Antineoplastic
Chemotherapy Protocol, Cancer
Chemotherapy Protocols, Antineoplastic
Chemotherapy Protocols, Cancer
Protocol, Antineoplastic Chemotherapy
Protocol, Cancer Chemotherapy
Protocols, Antineoplastic Chemotherapy
Protocols, Cancer Chemotherapy



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey